HomeCSL • ASX
add
CSL Ltd
Nakaraang pagsara
$285.09
Sakop ng araw
$278.14 - $280.46
Sakop ng taon
$265.14 - $313.55
Market cap
135.58B AUD
Average na Volume
530.19K
P/E ratio
31.85
Dividend yield
0.99%
Primary exchange
ASX
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 3.37B | 10.14% |
Gastos sa pagpapatakbo | 1.05B | 12.78% |
Net na kita | 370.50M | 29.77% |
Net profit margin | 10.98 | 17.81% |
Kita sa bawat share | — | — |
EBITDA | 788.00M | 3.01% |
Aktuwal na % ng binabayarang buwis | 20.28% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.66B | 7.04% |
Kabuuang asset | 38.02B | 4.93% |
Kabuuang sagutin | 18.62B | 1.16% |
Kabuuang equity | 19.40B | — |
Natitirang share | 483.25M | — |
Presyo para makapag-book | 7.93 | — |
Return on assets | 4.22% | — |
Return on capital | 5.08% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 370.50M | 29.77% |
Cash mula sa mga operasyon | 847.50M | 4.57% |
Cash mula sa pag-invest | -278.50M | 22.53% |
Cash mula sa financing | -235.00M | 43.37% |
Net change in cash | 316.00M | 1,139.22% |
Malayang cash flow | 348.19M | 93.30% |
Tungkol
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Itinatag
1916
Headquarters
Website
Mga Empleyado
32,698
